Found 4 matching trials
Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects
PHASE1The primary purpose of this study is to explore the safety and tolerability...
Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
PHASE2Study to evaluate the safety, tolerability, antitumor activity, and pharmac...
MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.
PHASE1A Phase 1b/2, open-label, randomized study to evaluate MEDI-573 in combinat...
A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors
PHASE1Evaluate the safety and tolerability of MEDI-573 in adult subjects with adv...